Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Inflammatory Bowel Diseases

Free Subscription 25.02.2019 1 Aliment Pharmacol Ther 1 Clin Gastroenterol Hepatol 1 Gastroenterology 5 Inflamm Bowel Dis 2 J Pediatr 1 PLoS One 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. DROBNE D, Kurent T, Golob S, Svegl P, et al
   Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel disease.
   Aliment Pharmacol Ther. 2019 Feb 19. doi: 10.1111/apt.15179.
   PubMed     Text format     Abstract available
   
   

   
   Clin Gastroenterol Hepatol

2. ZANOLI L
   Increased Cardiovascular Risk in Patients With Inflammatory Bowel Disease.
   Clin Gastroenterol Hepatol. 2019;17:799-800.
   PubMed     Text format    
   
   

   
   Gastroenterology

3. KORZENIK J
   Don't Worry, Be Happy: Psychological interventions in Inflammatory Bowel Disease.
   Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30386.
   PubMed     Text format    
   
   

   
   Inflamm Bowel Dis

4. HANSEN TM, Targownik LE, Karimuddin A, Leung Y, et al
   Management of Biological Therapy Before Elective Inflammatory Bowel Disease Surgeries.
   Inflamm Bowel Dis. 2019 Feb 22. pii: 5362644. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
5. DANILUK U, Daniluk J, Kucharski R, Kowalczyk T, et al
   Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn's Disease and Ulcerative Colitis-A Preliminary Study.
   Inflamm Bowel Dis. 2019 Feb 17. pii: 5321879. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
6. EAST JE, Boyapati RK, Torres J, Parker CE, et al
   Controversies in Inflammatory Bowel Disease: Exploring Clinical Dilemmas Using Cochrane Reviews.
   Inflamm Bowel Dis. 2019;25:472-478.
   PubMed     Text format     Abstract available
   
   
7. MARCIL V, Levy E, Amre D, Serban D, et al
   A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?
   Inflamm Bowel Dis. 2019 Feb 22. pii: 5320531. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
8. YAN P, Wang Y, Meng X, Yang H, et al
   Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
   Inflamm Bowel Dis. 2019 Feb 22. pii: 5362640. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Pediatr

9. HORNEFF G, Seyger MMB, Arikan D, Kalabic J, et al
   Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease.
   J Pediatr. 2018;201:166-175.
   PubMed     Text format     Abstract available
   
   
10. HASHKES PJ
    Do you have patients treated with adalimumab? Know the safety profile.
    J Pediatr. 2018;201:2-3.
    PubMed     Text format    
    
    

    
    PLoS One

11. ARTHUR S, Singh S, Sundaram U
    Cyclooxygenase pathway mediates the inhibition of Na-glutamine co-transporter B0AT1 in rabbit villus cells during chronic intestinal inflammation.
    PLoS One. 2018;13:e0203552.
    PubMed     Text format     Abstract available
    
    

    
    Scand J Gastroenterol

12. VENTURIERI MO, Komati JTS, Lopes LHC, Sdepanian VL, et al
    Treatment with Noripurum EV((R)) is effective and safe in pediatric patients with inflammatory bowel disease and iron deficiency anemia.
    Scand J Gastroenterol. 2019 Feb 20:1-7. doi: 10.1080/00365521.2019.1570326.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: